Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
GenSight Biologics has successfully completed a fundraising of €1 million, supported by existing shareholders.
Amount Raised
€1 Million
Round Type
Seed
ParisBiotechnologyHealth CareTherapeuticsBiopharmaDescription
GenSight Biologics, a biopharmaceutical company specializing in innovative gene therapies, has announced the successful completion of a fundraising of €1 million. This fundraising was backed by its existing shareholders. The announcement follows a previous announcement made on October 8, 2026. The company continues to focus on developing treatments for neurodegenerative retinal diseases.
Fundz sees it the moment GenSight Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
GenSight Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.